| Q33864464 | Differential diagnosis between intraductal papillary mucinous neoplasm with an associated invasive carcinoma and pancreatic ductal adenocarcinoma on ultrasonography: the utility of echo intensity and contrast enhancement. |
| Q36849427 | Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis |
| Q84972251 | Invasive IPMN and MCN: Same Organ, Sifferent Outcomes? |
| Q33987127 | Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes |
| Q37782570 | Malignant potential of intraductal papillary mucinous neoplasms of the pancreas |
| Q36369793 | Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis - a case report |
| Q36181596 | Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience |
| Q36055277 | Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting |
| Q37249683 | Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes |
| Q33597332 | Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center |
| Q51786173 | Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. |